Mitochondrial DNA variants in a Japanese population of patients with Alzheimer's disease

被引:38
作者
Tanaka, Noriko [1 ,2 ]
Goto, Yu-ichi [2 ]
Akanuma, Jun [2 ]
Kato, Mayuko [2 ]
Kinoshita, Toru [2 ]
Yamashita, Fumio [2 ]
Tanaka, Masashi [3 ]
Asada, Takashi [4 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[2] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan
[3] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo 1730015, Japan
[4] Univ Tsukuba, Inst Clin Med, Dept Neuropsychiat, Tsukuba, Ibaraki 3058571, Japan
关键词
mtDNA; Alzheimer disease; Rare variant; Association study; APOE; Sequencing; APOLIPOPROTEIN E4; MTDNA HAPLOGROUPS; OXIDATIVE DAMAGE; TRANSGENIC MICE; MUTATIONS; BRAIN; INSULIN; EXPRESSION; GENOME; TRANSCRIPTION;
D O I
10.1016/j.mito.2009.08.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The evidence for the role of mitochondria in Alzheimer's disease (AD) has been well investigated, based on the amyloid hypothesis and its relation to the mitochondrial dysfunction due to oxidative stress. However, contrasting reports describe an unclear picture on the relationship between AD and mitochondrial DNA (mtDNA) variations. Therefore, we analyzed complete mtDNA sequences from 153 AD patients and 129 normal control subjects to determine if inherited mtDNA polymorphisms or rare variants, or both contribute to the etiology of late-onset AD. The results reported herein indicate that inherited mtDNA common polymorphisms could not be the single major causes of AD but that some rare variants in the protein-coding-region may have protective effects for high-risk populations with the APOE e4 allele. Furthermore, our results support the idea that the np956-965 poly-c insertion and 856A>G variant might be a riskfactor for AD. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 53 条
  • [1] Saami and Berbers - An unexpected mitochondrial DNA link
    Achilli, A
    Rengo, C
    Battaglia, V
    Pala, M
    Olivieri, A
    Fornarino, S
    Magri, C
    Scozzari, R
    Babudri, N
    Santachiara-Benerecetti, AS
    Bandelt, HJ
    Semino, O
    Torroni, A
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (05) : 883 - 886
  • [2] Two pathogenic point mutations exist in the authentic mitochondrial genome, not in the nuclear pseudogene
    Akanuma, J
    Muraki, K
    Komaki, H
    Nonaka, I
    Goto, Y
    [J]. JOURNAL OF HUMAN GENETICS, 2000, 45 (06) : 337 - 341
  • [3] Asada T, 2000, SLEEP, V23, P629
  • [4] Effect of length variations at nucleotide positions 303-315 in human mitochondrial DNA on transcription termination
    Asari, Masaru
    Tan, Yuka
    Watanabe, Satoshi
    Shimizu, Keiko
    Shiono, Hiroshi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (03) : 641 - 644
  • [5] Beal MF, 1998, ANN NEUROL, V44, pS110
  • [6] Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment
    Beal, MF
    [J]. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2004, 36 (04) : 381 - 386
  • [7] Mitochondrial involvement in Alzheimer's disease
    Bonilla, E
    Tanji, K
    Hirano, M
    Vu, TH
    DiMauro, S
    Schon, EA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1410 (02): : 171 - 182
  • [8] Buttini M, 1999, J NEUROSCI, V19, P4867
  • [9] Cacabelos Ramon, 2005, Methods Find Exp Clin Pharmacol, V27 Suppl A, P1
  • [10] Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease
    Carrieri, G
    Bonafè, M
    De Luca, M
    Rose, G
    Varcasia, O
    Bruni, A
    Maletta, R
    Nacmias, B
    Sorbi, S
    Corsonello, F
    Feraco, E
    Andreev, KF
    Yashin, AI
    Franceschi, C
    De Benedictis, G
    [J]. HUMAN GENETICS, 2001, 108 (03) : 194 - 198